<DOC>
	<DOCNO>NCT00003777</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Drugs amifostine may prevent side effect radiation therapy . Combining one drug combine radiation therapy surgery chemotherapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine surgery , radiation therapy , combination chemotherapy treat patient recurrent head neck cancer treat previously radiation therapy .</brief_summary>
	<brief_title>Surgery , Radiation Therapy , Combination Chemotherapy Treating Patients With Recurrent Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine effectiveness toxic effect intensive salvage therapy radiotherapy previously irradiate patient recurrent head neck cancer . - Determine feasibility effectiveness amifostine limit minimize side effect repeat irradiation patient . OUTLINE : Patients undergo surgical resection gross disease ( already do ) follow 4-6 week rest . Patients receive radiotherapy 5 consecutive day week 1 , 2 , 4 , 5 . Intravenous cisplatin administer day 1-3 29-31 . Intravenous amifostine administer 15-30 minute prior radiotherapy cisplatin therapy . Patients receive fluorouracil IV continuously day 1-4 29-32 . Patients follow every month 1 year , every 2 month 1 year , every 3 month 1 year , every 4 month 1 year , every 6 month thereafter . PROJECTED ACCRUAL : A total 35 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent new primary squamous cell carcinoma head neck occur previously irradiate field Pathologic stage recurrence must rT34 and/or rN23 The following site eligible : Oral cavity , oropharynx , hypopharynx : Any rT24 and/or clinical rN+ Larynx : Any rT4 , rT3 perineural invasion , rT clinical rN+ Any site : Positive margin ( ) , least 2 node ECS No primary tumor nasopharynx Must eligible undergone complete resection leave behind gross residual disease Must prior head neck irradiation 4575 Gy Lifetime spinal cord radiotherapy dose great 50 Gy No ongoing RTOG late morbidity grade 3 great ( unless correctable surgery ) No active acute radiation mucositis previous radiotherapy PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : WBC least 4,000/mm^3 Hemoglobin least 9 g/dL ( transfusion allow ) Platelet count least 100,000/mm^3 Hepatic : SGOT SGPT great 3 time upper limit normal Bilirubin great 2 mg/dL Renal : Creatinine great 1.5 mg/dL Cardiovascular : No myocardial infarction , unstable angina , coronary heart failure , uncontrolled arrhythmia within past 6 month No severe cerebrovascular disease hypotension cause antihypertensive medication Other : Not pregnant Fertile patient must use effective contraception No allergy cisplatin , fluorouracil , amifostine No uncontrolled insulindependent diabetes mellitus medical condition interfere wound heal PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy tumor recurrence ( except adjuvant chemotherapy ) Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 6 month since prior radiotherapy Prior radiotherapy treatment record must available Surgery : No prior salvage surgery consist partial laryngectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2002</verification_date>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage IV lip oral cavity cancer</keyword>
	<keyword>recurrent lip oral cavity cancer</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage IV hypopharyngeal cancer</keyword>
	<keyword>recurrent hypopharyngeal cancer</keyword>
	<keyword>stage III laryngeal cancer</keyword>
	<keyword>stage IV laryngeal cancer</keyword>
	<keyword>recurrent laryngeal cancer</keyword>
	<keyword>stage III paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage IV paranasal sinus nasal cavity cancer</keyword>
	<keyword>recurrent paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage IV oropharyngeal cancer</keyword>
	<keyword>recurrent oropharyngeal cancer</keyword>
</DOC>